Conjugation of antibodies with bifunctional chelating agents: isothiocyanate and bromoacetamide reagents, methods of analysis, and subsequent addition of metal ions.
about
Dual-labeling strategies for nuclear and fluorescence molecular imaging: a review and analysisComparison of (64)Cu-complexing bifunctional chelators for radioimmunoconjugation: labeling efficiency, specific activity, and in vitro/in vivo stability.p-Isothiocyanatobenzyl-desferrioxamine: a new bifunctional chelate for facile radiolabeling of monoclonal antibodies with zirconium-89 for immuno-PET imagingRates and equilibria for probe capture by an antibody with infinite affinity.Detection of intestinal inflammation by MicroPET imaging using a (64)Cu-labeled anti-beta(7) integrin antibody.Immuno-PET imaging of tumor endothelial marker 8 (TEM8)Imaging cancer using PET--the effect of the bifunctional chelator on the biodistribution of a (64)Cu-labeled antibodyPET and MRI of metastatic peritoneal and pulmonary colorectal cancer in mice with human epidermal growth factor receptor 1-targeted 89Zr-labeled panitumumab.Combination of isothermal titration calorimetry and time-resolved luminescence for high affinity antibody-ligand interaction thermodynamics and kineticsComparative biodistributions of indium-111-labelled macrocycle chimeric B72.3 antibody conjugates in tumour-bearing miceTumor-specific targeting by Bavituximab, a phosphatidylserine-targeting monoclonal antibody with vascular targeting and immune modulating properties, in lung cancer xenografts.Macrocyclic chelates of radiometals for diagnosis and therapy.Affibody modified and radiolabeled gold-iron oxide hetero-nanostructures for tumor PET, optical and MR imagingA novel immunoscintigraphy technique using metabolizable linker with angiotensin II treatment.Improved radiotracing of oxytocin receptor-expressing tumours using the new [111In]-DOTA-Lys8-deamino-vasotocin analoguePreparation & in vitro evaluation of ⁹⁰Y-DOTA-rituximabZirconium-89 labeled panitumumab: a potential immuno-PET probe for HER1-expressing carcinomas.Metallic radionuclides in the development of diagnostic and therapeutic radiopharmaceuticals.ImmunoPET Imaging of CD146 Expression in Malignant Brain TumorsAntibodies with infinite affinity.CD146-targeted immunoPET and NIRF Imaging of Hepatocellular Carcinoma with a Dual-Labeled Monoclonal Antibody.A transition metal complex (Venus flytrap cluster) for radioimmunodetection and radioimmunotherapy.Comparison of the octadentate bifunctional chelator DFO*-pPhe-NCS and the clinically used hexadentate bifunctional chelator DFO-pPhe-NCS for 89Zr-immuno-PETTransfer of oxygen from an artificial protease to peptide carbon during proteolysis.Preparation of clinical-grade (89) Zr-panitumumab as a positron emission tomography biomarker for evaluating epidermal growth factor receptor-targeted therapy.The synthesis and application of polyamino polycarboxylic bifunctional chelating agents.Radiolabeling strategies for tumor-targeting proteinaceous drugs.Developments and recent advancements in the field of endogenous amino acid selective bond forming reactions for bioconjugation.Preclinical evaluation of radiolabelled nimotuzumab, a promising monoclonal antibody targeting the epidermal growth factor receptor.An integrated approach to identify normal tissue expression of targets for antibody-drug conjugates: case study of TENB2.Lanthanides as probes for time-resolved fluorometric immunoassays.Dose, timing, schedule, and the choice of targeted epitope alter the efficacy of anti-CD22 immunotherapy in mice bearing human lymphoma xenografts.A new bifunctional chelating agent conjugated with monoclonal antibody and labelled with technetium-99m for targeted scintigraphy: 6-(4-isothiocyanatobenzyl)-5,7-dioxo-1,11-(carboxymethyl)-1,4,8,11-tetraazacyclotridecane.Catabolism of (64)Cu and Cy5.5-labeled human serum albumin in a tumor xenograft model.Preclinical immunoPET/CT imaging using Zr-89-labeled anti-PD-L1 monoclonal antibody for assessing radiation-induced PD-L1 upregulation in head and neck cancer and melanoma.
P2860
Q27027682-917319C9-56F7-41E7-8C1B-16548A62D308Q27339846-1AFA7DA6-74A0-4FE8-86FC-58190495B861Q33629386-B03B79F1-3F63-4EFE-8ADF-443F024FEEE0Q33821333-257F03D7-F7D9-4B0B-A02C-45A8F78AA0CFQ34091752-ED46DB0B-2838-4718-A6C7-E54D3D343F57Q34473434-101BCB54-0B53-482B-8D7C-1EDD2002651FQ34545866-38B5A54D-F0C3-4BE7-987C-43FCA0994ED0Q35655093-1623339D-3778-4BC3-AB90-934AD7825512Q35803146-6F7D7CFD-05AD-4E22-9A1E-F6A00BFC0AE6Q36079405-47C534BD-BF5D-4BBD-858A-AEE0FF766FDAQ36205162-3EA44C5B-C15A-4F88-93F6-7CF52833D711Q36290948-117B4525-C678-496B-98FD-FE5878B4424EQ36585770-F9C2B2F3-F3E9-4058-8984-39642638722AQ36619359-3DC8B927-9E44-4D77-A758-EDA4885050BAQ36671779-468B4253-E7C2-4FBC-94A3-16E6E18E0D0CQ36769707-724EF34B-939A-4845-9B23-EBC9742E81CEQ36799494-DD5DF9CC-6D21-4B05-951F-463D4627890EQ37026964-4C6F9A46-1E7F-4EFE-804C-D3CEAD9DAEEEQ37072090-B7AA3E4E-7A40-4EE5-95E3-9CB551E44F62Q37101644-2CE20B29-642B-47D9-8864-39E6CEACB3A6Q37202324-FD73920E-DDA0-490A-8FF4-DB0CA3993C37Q37486015-1650C9B6-6080-416E-852B-A2D6BE78DAD8Q37560052-64375CC3-380C-4D1B-8C5A-B19CF3793C2FQ37631018-F908C5DB-674A-4464-ABA1-BF80EF8772DCQ37696236-75B6CD67-4061-4A06-AAA2-DA88A4FB3ED7Q37850696-975EF45F-7A7B-4853-960A-0919137E80A2Q38189541-D8B1D420-5735-4737-B131-B6E64475F1A8Q38497871-ADBED543-9B7B-4C09-AAC5-D001AD508F2BQ39052926-2021747A-D45D-44E4-A66A-FB4F8E4928EBQ39298392-554529C8-7C34-4754-9392-09B522844EEEQ39550261-AF71EDD7-08AB-43BC-A569-33DB251BA3EAQ39852397-4DC8B11E-C1CA-4EFC-AF99-3568B6F9D029Q45204018-893A748B-7DE6-4FFA-B87D-063E91A1B3C1Q53118142-4ABBA06E-7CA3-4554-BE9D-79CF6A2EAC5DQ55224585-A7083F75-63B0-4B62-AA3A-C7CCDBAB5D17
P2860
Conjugation of antibodies with bifunctional chelating agents: isothiocyanate and bromoacetamide reagents, methods of analysis, and subsequent addition of metal ions.
description
1984 nî lūn-bûn
@nan
1984年の論文
@ja
1984年論文
@yue
1984年論文
@zh-hant
1984年論文
@zh-hk
1984年論文
@zh-mo
1984年論文
@zh-tw
1984年论文
@wuu
1984年论文
@zh
1984年论文
@zh-cn
name
Conjugation of antibodies with ...... equent addition of metal ions.
@en
Conjugation of antibodies with ...... equent addition of metal ions.
@nl
type
label
Conjugation of antibodies with ...... equent addition of metal ions.
@en
Conjugation of antibodies with ...... equent addition of metal ions.
@nl
prefLabel
Conjugation of antibodies with ...... equent addition of metal ions.
@en
Conjugation of antibodies with ...... equent addition of metal ions.
@nl
P2093
P1476
Conjugation of antibodies with ...... equent addition of metal ions.
@en
P2093
P356
10.1016/0003-2697(84)90517-7
P407
P577
1984-10-01T00:00:00Z